Doctor Rafael Rascon Sabido

Doctor Rafael Rascon Sabido

Mexican Institute of Social Security (IMSS), Veracruz (Mexico)

Dr. Rafael Rascon its Cardiologist from Veracruz Mexico, have a specialty in Echocardiography, and clinical experience in Acute Care and Cardioncology. Have a Master en Transesophageal echo for UMP Madrid. Spain.

Presentations

Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis

Event: Heart Failure 2024

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 6

Access

Safety and use de trimetazidine in Cancer Therapy-Related Cardiac Dysfunction (CTRCD) secondary to breast cancer for LVEF recovery.

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 2

Access

Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life

Event: Heart Failure 2024

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic heart failure - pathophysiology and mechanisms 3

Access

Efficacy of half-dose intermittent levosimendan in day hospital for reduce mortality and hospitalization in patients with heart failure and reduced ejection fraction

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - treatment 4

Access

Left bundle branch block correction with conduction system pacing in a heart failure patient

Event: Heart Failure 2023

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac resynchronization therapy

Access

Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 2

Access

Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients.

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 5

Access

Hydrochlorothiazide for the treatment of acute volume overload worsening heart failure

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 3

Access

Evaluation of right atrial and ventricular function with 3D echocardiography in acute pulmonary thromboembolism and its 6-month prognosis

Event: EuroEcho-Imaging 2018

Topic: 3D Echocardiography

Session: 3D Echocardiography

Access

Prevalence and risk factors for ventricular remodeling and pulmonary arterial hypertension in systemic erythematosus lupus

Event: EuroEcho-Imaging 2018

Topic: Morphology, Dimensions, Volumes and Mass

Session: Echocardiography: Dimensions, Volumes and Mass

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Rafael Rascon Sabido

Biography

Contributor content

Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis

Safety and use de trimetazidine in Cancer Therapy-Related Cardiac Dysfunction (CTRCD) secondary to breast cancer for LVEF recovery.

Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life

Efficacy of half-dose intermittent levosimendan in day hospital for reduce mortality and hospitalization in patients with heart failure and reduced ejection fraction

Left bundle branch block correction with conduction system pacing in a heart failure patient

Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients.

Hydrochlorothiazide for the treatment of acute volume overload worsening heart failure

Evaluation of right atrial and ventricular function with 3D echocardiography in acute pulmonary thromboembolism and its 6-month prognosis

Prevalence and risk factors for ventricular remodeling and pulmonary arterial hypertension in systemic erythematosus lupus

ESC 365 is supported by

Doctor Rafael Rascon Sabido Follow

Biography

Contributor content

Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis

Safety and use de trimetazidine in Cancer Therapy-Related Cardiac Dysfunction (CTRCD) secondary to breast cancer for LVEF recovery.

Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life

Efficacy of half-dose intermittent levosimendan in day hospital for reduce mortality and hospitalization in patients with heart failure and reduced ejection fraction

Left bundle branch block correction with conduction system pacing in a heart failure patient

Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients.

Hydrochlorothiazide for the treatment of acute volume overload worsening heart failure

Evaluation of right atrial and ventricular function with 3D echocardiography in acute pulmonary thromboembolism and its 6-month prognosis

Prevalence and risk factors for ventricular remodeling and pulmonary arterial hypertension in systemic erythematosus lupus

ESC 365 is supported by

Doctor Rafael Rascon Sabido